SEC Form 4 · accession 0001144204-17-043763

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Exec. VP, Corporate Strategy · Director

Period of report

Aug 14, 2017

Accepted (ET)

Aug 16, 2017 · 9:07 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock	Aug 14, 2017	M	300	$11.83	A	300	D
Class A Common Stock^F2	Aug 14, 2017	S	300	$40.08	D	0	D
Class A Common Stock	Aug 15, 2017	M	1,443	$11.83	A	1,443	D
Class A Common Stock^F3	Aug 15, 2017	S	1,443	$40.05	D	0	D
Class A Common Stock	Aug 16, 2017	M	5,938	$11.83	A	5,938	D
Class A Common Stock^F4	Aug 16, 2017	S	5,938	$40.04	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to purchase Common Stock	$11.83	Aug 14, 2017	M	300	D	Mar 1, 2012	Feb 28, 2019	Class A Common Stock	300	39,480	D
Option to purchase Common Stock	$11.83	Aug 15, 2017	M	1,443	D	Mar 1, 2012	Feb 28, 2019	Class A Common Stock	1,443	38,037	D
Option to purchase Common Stock	$11.83	Aug 16, 2017	M	5,938	D	Mar 1, 2012	Feb 28, 2019	Class A Common Stock	5,938	32,099	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2017.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.25, inclusive.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.15, inclusive.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.13, inclusive.